A critical discovery in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many forms of malignancies, leading https://bookmarknap.com/story12572198/mini-antibodies-restore-p53-a-promising-approach-for-tumor-therapy